The present results suggest an involvement of renin gene expression in the NTN mouse independent of T2DM, chronic hypertension, and atherosclerosis, pointing to potential beneficial effects of GLP‐1R agonist treatment relevant for several forms of nephropathy. This evidence concerns the gene REN and type 2 diabetes mellitus.